Autologous Bone Marrow Transplantation - Blog Science Connections

Treatment Strategies for NHL 305
patients in relapse are possibly salvaged by high-dose chemotherapy with
ABMT. However, the value of such chemotherapy and ABMT as a salvage
treatment in comparison with alternative conventional-dose regimens has yet to
be determined. Finally, for PRD patients the salvage possibilities are limited:
their therapy options should be examined in phase II studies.
REFERENCES
1. Rappaport H. In Atlas of Tumor Pathology, fascicle 8. Armed Forces Institute of Pathology,
Washington, D.C., 1966.
2. Jones SE, Fuks Z, Kaplan HS, Rosenberg SA. Cancer 1973;32:682.
3. DeVita VT, Chabner B, Hubbard SP, Canellos GP, Schein P, Young RC. Lancet 1975;1:248.
4. Fisher Rl, DeVita VT, Johnson BL, Simon R, Young R. Am J Med 1977^3:177.
5. McKelvey EM, Gottlier JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF,
Jones SE, Grozea PN, Gutterman J, Coltman C, Moon TE. Cancer 1976:38:1484.
6. Armitage JO, Dick FR, Corder MP. Cancer 1982;38:1484.
7. Blackledge G, Bush H, Chang J. Eur J Cancer Clin Oncol 1980;16:1459.
8. Parlier Y, Gorin NC, Najman A. Cancer 1982:50:401.
9. Armitage JO, Fyfe MAE, Lewis J. J Clin Oncol 1984;2(8):898.
10. Elias L, Portlock CS, Rosenberg SA. Cancer 1978:42:1705.
11. Coltman CA, Luce JK, McKelvey EM, Jones SE, Moon TE. Cancer Treat Rep 1977;61:1067.
12. Skarin AT, Canellos GP, Rosenthal DS, Case DC, Maclntyre JM, Pinkus GS, Moloney WC, Frei E.
J Clin Oncol 1983;1(2):91.
13. Fisher Rl, DeVita VT, Hubbard SM, Longo DL, Wesley R, Chabner BA, Young RC. Ann Intern Med
1983:98304.
14. Cabanillas F, Burgess MA, Bodey GP, Freireich EJ. Am J Med 1983;74:382.
15. Coiffier B, Bryon PA, Berger F, Archimbaud E, Ffrench M, Extra JM, Guyotat D, Fiere D,
Gentilhomme O, Magaud JP, Blanc M, Peaud PY, Vuvan H, VialaJJ.J Clin Oncol 1986;4(2):147.
16. Klimo P, Connors JM. Ann Intern Med 1985:102:596.
17. Singer CRJ, Goldstone AH. Clin Haematol 1986;15(1):105.
18. Rosenberg SA, Berard CW, Brown BW. Cancer 1982;49:2112.
19. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Cancer Res 1971:31:1860.
20. Philip T, Lenoir GM, Favrot M, Philip 1. In Hemopathies Malignes, Zittoun R, ed. Flammarion
Médecine-Sciences, Paris, 1986:437.
21. Wollner N, Exelby PR, Lieberman PH. Cancer 1979;44:1990.
22. Cabanillas F, Hageméster FB, Riggs S, Salvador P, Velasquez W, McLaughlin P, Smith T. In
Malignant Lymphomas and Hodgkin's Disease: Experimental and Therapeutic Advances,
Cavalli F, ed. Martinus Nijhoff, Boston, 1985:485.
23. Skarin AT, Rosenthal DS, Moloney WC, Frei E. Blood 1977;49(5):759.
24. Schein PS, DeVita VT, Hubbard S, Chabner BA, Canellos GP, Berard C, Young RC. Ann Intern
Med 1976;85(4):417.
25. Rodriguez V, Cabanillas F, Burgess MA, McKelvey EM, Valdivieso M, Bodey GP, Freireich EJ.
Blood 1977:49:325.
26. Bodey GP, Rodriguez V, Cabanillas F, Freireich EJ. Am J Med 1979:66:74.
27. Ginsberg SJ, Crooke ST, Bloomfield CD, Peterson B, Kennedy BJ, Blom J, Ellison RR, Pajak TF,
Gottlieb AJ. Cancer 1982:49:1346.
28. Jagannath S, Velasquez WS, Tucker SL, Manning JT, McLaughlin P, Fuller LM. J Clin Oncol
1985;3(1 ):39.
29. Newcomer LN, Cadman EC, Nerenberg Ml. Cancer Treat Rep 1982:66:1279.
30. Jones SE, Grozea PN, Metz EM. Cancer 1979:38:1484.